Accelerated Biological Aging in Familial Pulmonary Fibrosis

Ana Serezani,Daphne B Mitchell,Joy D Cogan,Merced U Malabanan,Cheryl R Markin,Errine T Garnett,Katrina Douglas,Tisra H Fadely,Jonathan A Kropski,Margaret L Salisbury,Timothy S Blackwell

DOI: https://doi.org/10.1101/2024.10.10.24315235

2024-10-11

Abstract:Abstract Since Familial Pulmonary Fibrosis (FPF) manifests in older adults and telomere attrition is common in FPF and sporadic Idiopathic Pulmonary Fibrosis (IPF), we postulated that accelerated aging, as determined by epigenetic clock (DNA methylation) measurements, could occur in FPF. We measured DNAge from blood of patients with FPF and a group of first-degree relatives of FPF patients without disease (termed at-risk for FPF) with or without genetic rare variants (RVs) in telomerase pathway genes. We observed accelerated epigenetic aging with increased DNAge compared to chronological age in individuals at-risk for FPF and FPF patients compared to healthy controls. We found that increased DNAge manifests independently of the presence of RVs in telomerase pathway genes or telomere length in peripheral blood cells. These findings suggest that increased DNAge could be an independent risk factor for the development of FPF.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: whether there is an accelerated biological aging phenomenon in patients with Familial Pulmonary Fibrosis (FPF) and their immediate relatives, and whether this accelerated aging is related to telomere length or rare variants (RVs) in telomere - related genes. Specifically, researchers evaluated the epigenetic age of these individuals by measuring the DNA methylation level in blood samples and compared it with the actual physiological age to explore whether accelerated epigenetic aging could be an independent risk factor for FPF.

### Research Background
1. **Familial Pulmonary Fibrosis**: FPF is a disease that mainly occurs in the elderly, characterized by the gradual thickening and hardening of lung tissue, leading to symptoms such as dyspnea. It is known that telomere shortening is related to the occurrence of FPF. The telomere length in peripheral blood cells and lung epithelial cells of about 40% of FPF patients and 25% of Idiopathic Pulmonary Fibrosis (IPF) patients is lower than the 10th percentile of the normal range.
2. **Epigenetics and Aging**: Epigenetic changes, especially changes in DNA methylation patterns, are considered important indicators for measuring the biological age of cells and tissues. These changes can affect gene expression and, in turn, cell function. The biological age of most people is consistent with their actual age, but in some chronic diseases, individuals may show accelerated epigenetic aging.

### Research Purposes
- **Evaluating Accelerated Epigenetic Aging**: By measuring the DNA methylation level of FPF patients and their immediate relatives, evaluate whether their epigenetic age is significantly higher than their actual age.
- **Exploring the Causes of Accelerated Aging**: Analyze whether the accelerated epigenetic aging is related to telomere length or rare variants in telomere - related genes.

### Main Findings
- **Accelerated Epigenetic Aging**: The study found that the epigenetic age of FPF patients and "high - risk" relatives was significantly higher than that of the healthy control group, indicating the existence of accelerated epigenetic aging.
- **Relationship with Telomere Length**: Although FPF patients with shorter telomere lengths showed a higher epigenetic age difference (ΔDNAge), overall, the correlation between epigenetic age and telomere length was weak.
- **Relationship with Rare Variants**: There was no significant difference in epigenetic age difference between individuals with or without rare variants in telomere - related genes.
- **Association with Sub - clinical Diseases**: Among "high - risk" relatives, whether there was sub - clinical FPF (such as interstitial lung abnormalities shown by CT scans) or not, there was no significant difference in epigenetic age difference.

### Conclusions
The results of this study indicate that accelerated epigenetic aging may be an independent risk factor for FPF, and this accelerated aging may already exist in "high - risk" relatives before the disease occurs. This provides a new perspective for the early identification and prevention of FPF. However, the study also pointed out some limitations, such as a small sample size and a lack of longitudinal data, which limit the comprehensive assessment of the progress of biological aging.